BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260506
DTSTAMP:20260525T105655
CREATED:20251206T101622Z
LAST-MODIFIED:20260125T043207Z
UID:9626-1777852800-1778025599@thebiocalendar.com
SUMMARY:TRI-CON 2026
DESCRIPTION:Join us for an exclusive gathering of senior-level investors\, pharma executives\, entrepreneurs\, research thought leaders\, and innovators at the 33rd Annual TRI-CON. Connect with investors and partners at intimate networking sessions; gain strategic insights on funding activities\, business development\, and innovation strategies in diagnostics\, precision medicine\, and AI from industry-led panels; and hear candid perspectives and business recommendations from key opinion leaders during dynamic fireside chats. Building on a 30+ track record\, TRI-CON is positioned as the premier meeting place for key stakeholders to foster meaningful connections\, acquire valuable strategic insights\, and drive innovation and collaboration. Returning to San Francisco in 2026!
URL:https://thebiocalendar.com/event/tri-con-2026/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
CATEGORIES:Featured,Investor,Networking,Partnering,Presentation,Summit
ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/01/tric-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260504
DTEND;VALUE=DATE:20260508
DTSTAMP:20260525T105655
CREATED:20260327T140336Z
LAST-MODIFIED:20260327T140336Z
UID:10105-1777852800-1778198399@thebiocalendar.com
SUMMARY:SynBioBeta 2026
DESCRIPTION:Join our SynBioBeta community for three days of high-signal talks\, curated 1:1 meetings\, real partnering\, and hands-on exposure at the frontier of biology and technology. \nGo deep on AI-driven biology and therapeutics. You’ll also get up to speed on sustainable biomanufacturing of chemicals\, materials\, food\, and consumer products\, and discover applications of biology that you never thought possible. \nThis is where global builders\, backers\, and scouts have mind-blowing conversations and find their next moves.
URL:https://thebiocalendar.com/event/synbiobeta-2026/
LOCATION:San Jose\, San Jose\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260505T110000
DTEND;TZID=America/Los_Angeles:20260505T120000
DTSTAMP:20260525T105655
CREATED:20260407T115320Z
LAST-MODIFIED:20260407T115320Z
UID:10138-1777978800-1777982400@thebiocalendar.com
SUMMARY:Organs-on-Chips: Tech Progress & Regulatory Tailwinds
DESCRIPTION:Microphysiological (MPS) systems are proving to be increasingly valuable for early drug discovery. By recreating human‑specific physiology—fluid flow\, barrier function\, multicellular interactions\, and organ‑level mechanics—organ‑on‑chip models generate insight that’s difficult to obtain from traditional cell lines or animals. They support target validation research and they enable early efficacy modeling for processes like neuroinflammation\, fibrosis\, barrier breakdown\, infection\, and metabolic dysfunction. Liver\, kidney\, lung\, gut\, cervix\, and BBB chips can also provide early tox\, PK/PD\, and ADME readouts; measuring metabolism\, clearance\, permeability\, and drug–drug interactions. Beyond these core areas\, chips offer windows into disease modeling\, including patient‑specific biology using iPSC‑derived cells\, and help de‑risk newer modalities that need human‑relevant microenvironments to behave predictably. Together\, these capabilities make MPS one of the most important emerging tools for building human biology into discovery from the start\, not just for avoiding late‑stage toxicology failures. \nThe panel will discuss the progress being made in these key areas and provide insight into the future of organ-on-chip model research. Register for free today.
URL:https://thebiocalendar.com/event/organs-on-chips-tech-progress-regulatory-tailwinds/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/04/26_05_DDO_HTML_600x300.png
END:VEVENT
END:VCALENDAR